Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study

ABSTRACT:

SUBMITTER: Dermitzakis E 

PROVIDER: S-EPMC11674050 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature